This comparison with the published literature further supports our findings that grade 2/3 astrocytomas with CDKN2A homozygous deletion as assessed by FISH have longer survival than histologic grade 4 tumors. Here, CDKN2A is linked to astrocytoma (excluding glioblastoma).